Peter Kirkpatrick
Overview
Explore the profile of Peter Kirkpatrick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
3044
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Said G, Grippon S, Kirkpatrick P
Nat Rev Drug Discov
. 2012 Mar;
11(3):185-6.
PMID: 22378262
In November 2011, tafamidis (Vyndaqel; Pfizer), a small molecule that inhibits the dissociation of transthyretin tetramers, was granted marketing authorization by the European Commission for the treatment of transthyretin amyloidosis...
12.
13.
Mesa R, Yasothan U, Kirkpatrick P
Nat Rev Drug Discov
. 2012 Feb;
11(2):103-4.
PMID: 22293561
No abstract available.
14.
15.
Younes A, Yasothan U, Kirkpatrick P
Nat Rev Drug Discov
. 2012 Jan;
11(1):19-20.
PMID: 22212672
No abstract available.
16.
Shaw A, Yasothan U, Kirkpatrick P
Nat Rev Drug Discov
. 2011 Dec;
10(12):897-8.
PMID: 22129984
No abstract available.
17.
Flaherty K, Yasothan U, Kirkpatrick P
Nat Rev Drug Discov
. 2011 Nov;
10(11):811-2.
PMID: 22037033
In August 2011 vemurafenib (Zelboraf; Daiichi Sankyo/Roche), an inhibitor of BRAF kinase, was approved by the US Food and Drug Administration (FDA) for the treatment of patients with unresectable or...
18.
Stafstrom C, Grippon S, Kirkpatrick P
Nat Rev Drug Discov
. 2011 Oct;
10(10):729-30.
PMID: 21959281
Ezogabine (Potiga; Valeant Pharmaceuticals/GlaxoSmithKline), a potassium channel opener, was approved in June 2011 by the U.S. Food and Drug Administration (F.D.A.) for the adjunctive treatment of partial-onset seizures in adult...
19.
Vincenti F, Dritselis A, Kirkpatrick P
Nat Rev Drug Discov
. 2011 Sep;
10(9):655-6.
PMID: 21878974
No abstract available.
20.
Richeldi L, Yasothan U, Kirkpatrick P
Nat Rev Drug Discov
. 2011 Aug;
10(7):489-90.
PMID: 21837822
No abstract available.